Realistic Mass Casualty Medical Simulation Capabilities RFI

The Biological Technologies Office of the Defense Advanced Research Projects Agency (DARPA) issued this Request for Information (RFI) to identify capabilities for planning, resourcing, executing, and assessing high-fidelity, large-scale mass casualty (MASCAL) medical simulation events. The agency seeks input from industry, government support organizations, military training organizations, and civilian emergency preparedness entities. This preliminary market research aims to assess current capabilities for conducting realistic simulations involving more than 50, 100, or 200 simulated patients within a single event lasting less than 72 hours.

This special notice, identified by solicitation number DARPA-SN-26-79, is categorized under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC AC12 for National Defense R&D Services; Department of Defense - Military; Applied Research. The RFI is intended solely for information gathering and planning purposes and does not constitute a formal solicitation for proposals or indicate an intent to provide funding. One attachment, a PDF titled DARPA-SN-26-79.pdf, was published alongside the notice on May 15, 2026.

Interested parties must submit their responses by May 31, 2026. The primary point of contact for this inquiry is Dr. Jeremy Pamplin within DARPA/BTO. The notice is issued by Departmental Offices and provides no specific place of performance or set-aside designation.